Skip to main content
Presentation
Systemically delivered Doxil® increases survival in both an intracranial gliosarcoma model and an intracranial metastatic breast cancer model in rodents.
American Association of Neurological Surgeons 79th Annual Meeting (2011)
  • Robert T Wicks, Baptist Health South Florida
Publication Date
April, 2011
Location
Denver, CO
Citation Information
Robert T Wicks. "Systemically delivered Doxil® increases survival in both an intracranial gliosarcoma model and an intracranial metastatic breast cancer model in rodents." American Association of Neurological Surgeons 79th Annual Meeting (2011)
Available at: http://works.bepress.com/robert-wicks/38/